EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
2018
Y 4.L 11/4:S.HRG.114-805
Linked e-resources
Linked Resource
Details
Title
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
Corporate Author
Published
Washington : U.S. Government Publishing Office, 2018.
Language
English
Description
iii, 43 pages : illustrations ; 24 cm.
Call Number
Y 4.L 11/4:S.HRG.114-805
GPO Item No.
1043-B (MF)
Note
Shipping list no.: 2019-0162-M.
Bibliography, etc. Note
Includes bibliographical references.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2018] 1 microfiche : negative.
Series
United States. Congress. Senate. S. hrg. ; 114-805.
Available in Other Form
Linked Resources
Record Appears in